Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
- Revenue
- +8.06%
- EPS
- +8.47%
- Free cash flow
- +69.5%
- Total debt
- +8.81%
Quarter to July 2026, against a year earlier
Follow A
Alert me
Agilent Technologies, Inc. (A) Price to free cash flow
As of 5 November 2026, Agilent Technologies, Inc. (A) trades at a price to free cash flow of 38.2×. Over the past ten years it has ranged from 20.4× (October 2016) to 59.6× (May 2015); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 36.0× | 30.58% |
| FY2024 | 27.6× | 33.51% |
| FY2023 | 20.7× | (49.16%) |
| FY2022 | 40.6× | 10.21% |
| FY2021 | 36.9× | (8.96%) |
| FY2020 | 40.5× | 47.45% |
| FY2019 | 27.5× | 20.31% |
| FY2018 | 22.8× | (25.69%) |
| FY2017 | 30.7× | 41.46% |
| FY2016 | 21.7× | (28.00%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jul 2026 | 30.7× | 2.76% |
| Apr 2026 | 29.9× | (22.30%) |
| Jan 2026 | 38.5× | 6.91% |
| Oct 2025 | 36.0× | 20.41% |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 20.3× |
| IQV IQVIA Holdings Inc. compare | 21.0× |
| LH Labcorp Holdings Inc. compare | 25.4× |
| ILMN Illumina, Inc. compare | 30.4× |
| A Agilent Technologies, Inc. | 38.2× |
| MTD Mettler-Toledo International, Inc. compare | 39.1× |
| IDXX IDEXX Laboratories, Inc. compare | 40.6× |
| WAT Waters Corporation compare | 173× |
| NTRA Natera, Inc. compare | 1,004× |
| Diagnostics & Research industry median | 33.5× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement